Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy

Review for "The interaction of lean body mass with fat body mass is associated with vertebral fracture prevalence in women with early breast cancer undergoing aromatase inhibitor therapy"

10.1002/jbm4.10440/v2/review1 ◽

2020 ◽

Author(s):

David Scott

Keyword(s):

Breast Cancer ◽

Vertebral Fracture ◽

Aromatase Inhibitor ◽

Lean Body Mass ◽

Body Mass ◽

Early Breast Cancer ◽

Fat Body ◽

Fracture Prevalence ◽

Review for "The interaction of lean body mass with fat body mass is associated with vertebral fracture prevalence in women with early breast cancer undergoing aromatase inhibitor therapy"

10.1002/jbm4.10440/v1/review1 ◽

2020 ◽

Author(s):

David Scott

Keyword(s):

Breast Cancer ◽

Vertebral Fracture ◽

Aromatase Inhibitor ◽

Lean Body Mass ◽

Body Mass ◽

Early Breast Cancer ◽

Fat Body ◽

Fracture Prevalence ◽

The Interaction of Lean Body Mass With Fat Body Mass Is Associated With Vertebral Fracture Prevalence in Women With Early Breast Cancer Undergoing Aromatase Inhibitor Therapy

JBMR Plus ◽

10.1002/jbm4.10440 ◽

2020 ◽

Author(s):

Sara Monteverdi ◽

Rebecca Pedersini ◽

Fabio Gallo ◽

Filippo Maffezzoni ◽

Alberto Dalla Volta ◽

...

Keyword(s):

Breast Cancer ◽

Vertebral Fracture ◽

Aromatase Inhibitor ◽

Lean Body Mass ◽

Body Mass ◽

Early Breast Cancer ◽

Fat Body ◽

Fracture Prevalence ◽

Decision letter for "The interaction of lean body mass with fat body mass is associated with vertebral fracture prevalence in women with early breast cancer undergoing aromatase inhibitor therapy"

10.1002/jbm4.10440/v1/decision1 ◽

2020 ◽

Keyword(s):

Breast Cancer ◽

Vertebral Fracture ◽

Aromatase Inhibitor ◽

Lean Body Mass ◽

Body Mass ◽

Early Breast Cancer ◽

Fat Body ◽

Fracture Prevalence ◽

Author response for "The interaction of lean body mass with fat body mass is associated with vertebral fracture prevalence in women with early breast cancer undergoing aromatase inhibitor therapy"

10.1002/jbm4.10440/v2/response1 ◽

2020 ◽

Author(s):

Sara Monteverdi ◽

Rebecca Pedersini ◽

Fabio Gallo ◽

Filippo Maffezzoni ◽

Alberto Dalla Volta ◽

...

Keyword(s):

Breast Cancer ◽

Vertebral Fracture ◽

Aromatase Inhibitor ◽

Lean Body Mass ◽

Body Mass ◽

Early Breast Cancer ◽

Fat Body ◽

Fracture Prevalence ◽

Decision letter for "The interaction of lean body mass with fat body mass is associated with vertebral fracture prevalence in women with early breast cancer undergoing aromatase inhibitor therapy"

10.1002/jbm4.10440/v2/decision1 ◽

2020 ◽

Keyword(s):

Breast Cancer ◽

Vertebral Fracture ◽

Aromatase Inhibitor ◽

Lean Body Mass ◽

Body Mass ◽

Early Breast Cancer ◽

Fat Body ◽

Fracture Prevalence ◽

Prevention of osteoporosis as a consequence of aromatase inhibitor therapy in postmenopausal women with early breast cancer: Rationale and design of a randomized controlled trial

Contemporary Clinical Trials ◽

10.1016/j.cct.2011.04.012 ◽

2011 ◽

Vol 32 (5) ◽

pp. 704-709 ◽

Cited By ~ 5

Author(s):

Sharon Kilbreath ◽

Kathryn M. Refshauge ◽

Jane Beith ◽

Leigh Ward ◽

Kate Sawkins ◽

...

Keyword(s):

Breast Cancer ◽

Randomized Controlled Trial ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Controlled Trial ◽

Inhibitor Therapy ◽

Randomized Controlled ◽

Prevention Of Osteoporosis

Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-011-1351-3 ◽

2011 ◽

Vol 126 (2) ◽

pp. 295-310 ◽

Cited By ~ 60

Author(s):

Susan F. Dent ◽

Rania Gaspo ◽

Michelle Kissner ◽

Kathleen I. Pritchard

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Management Strategies ◽

Inhibitor Therapy ◽

Hormone Sensitive

Bisphosphonates May Protect against Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Aromatase Inhibitor Therapy: Results from a Meta-analysis

Archives of Medical Research ◽

10.1016/j.arcmed.2014.10.007 ◽

2014 ◽

Vol 45 (7) ◽

pp. 570-579 ◽

Cited By ~ 3

Author(s):

Guoqiang Su ◽

Yi Xiang ◽

Guodong He ◽

Chenchun Jiang ◽

Chuang Li ◽

...

Keyword(s):

Breast Cancer ◽

Bone Loss ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Meta Analysis ◽

Inhibitor Therapy ◽

Aromatase Inhibitor Therapy

Patient's Anastrozole Compliance to Therapy (PACT) Program: Baseline Data and Patient Characteristics from a Population-Based, Randomized Study Evaluating Compliance to Aromatase Inhibitor Therapy in Postmenopausal Women with Hormone-Sensitive Early Breast Cancer

Breast Care ◽

10.1159/000350777 ◽

2013 ◽

Vol 8 (2) ◽

pp. 110-120 ◽

Cited By ~ 3

Author(s):

Nadia Harbeck ◽

Maria Blettner ◽

Peyman Hadji ◽

Christian Jackisch ◽

Hans-Joachim Lück ◽

...

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Early Breast Cancer ◽

Randomized Study ◽

Patient Characteristics ◽

Population Based ◽

Baseline Data ◽

Hormone Sensitive